Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
15,800
Employees15,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
15,800
Employees15,800

EW Key Statistics

Market cap
45.59B
Market cap45.59B
Price-Earnings ratio
43.13
Price-Earnings ratio43.13
Dividend yield
Dividend yield
Average volume
6.10M
Average volume6.10M
High today
$78.92
High today$78.92
Low today
$78.02
Low today$78.02
Open price
$78.60
Open price$78.60
Volume
494.48K
Volume494.48K
52 Week high
$87.89
52 Week high$87.89
52 Week low
$65.94
52 Week low$65.94

Stock Snapshot

The current Edwards Lifesciences(EW) stock price is $78.56, with a market capitalization of 45.59B. The stock trades at a price-to-earnings (P/E) ratio of 43.13.

On 2026-02-20, Edwards Lifesciences(EW) stock moved within a range of $78.02 to $78.92. With shares now at $78.56, the stock is trading +0.7% above its intraday low and -0.5% below the session's peak.

Trading volume for Edwards Lifesciences(EW) stock has reached 494.48K, versus its average volume of 6.1M.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.

EW News

Simply Wall St 17h
TAVR-Fueled Growth and 2026 Guidance Might Change The Case For Investing In Edwards Lifesciences

In February 2026, Edwards Lifesciences reported fourth-quarter 2025 sales of US$1,569.6 million alongside a sharp drop in quarterly net income, while issuing fi...

TAVR-Fueled Growth and 2026 Guidance Might Change The Case For Investing In Edwards Lifesciences

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
32.3%
Sell
0%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.